from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0510/hemC

LFCtreatmentdescriptionclass of inhibitor

0.080

Amikacinug/mL Amikacintranslation

0.425

Cap5-10ug/mL Capreomycintranslation

-0.176

Rox10-50 ug/mL Roxithromycintranslation

0.776

SM2-5 ug/mL Streptomycintranslation

0.162

Tet5-10 ug/mL Tetracyclinetranslation

-1.528

Rif0.2-5ug/mL Rifampicintranscription

-1.106

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.526

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.844

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.158

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.855

Clofazimine10-13 ug/mL Clofaziminerespiration

0.550

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.441

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.928

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.536

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.413

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.058

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.767

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.263

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.675

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.527

KCN5-20 ug/mL Potassium cyaniderespiration

0.231

NaN30.2-2 mM Sodium aziderespiration

-1.309

Nigericin50 uM Nigericinrespiration

-0.738

TRC10-150 ug/mL Triclosanrespiration

-1.404

TRZ10-25 ug/mL Thioridazinerespiration

0.060

Valinomycin0.5-10 uM Valinomycinrespiration

-0.009

ZnSO42 mM ZnSO4respiration

0.792

menadione6-10 ug/mL Menadionerespiration

-0.620

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.696

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.182

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.203

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.517

NRP_1Non-replicating persistence stage 1dosRassociated

0.465

Amp0.2mg/mL AmpicillincellWall

0.482

Cephalexin20-100 ug/mL CephalexincellWall

1.039

Cerulenin0.32-5 ug/mL CerulenincellWall

0.438

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.626

EMB10-20 ug/mL EthambutolcellWall

1.289

Eta12-40 ug/mL EthionamidecellWall

1.575

INH0.2-0.4 ug/mL IsoniazidcellWall

0.591

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.275

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.223

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.038

BZA0.12 mg/mL BenzamidearomaticAmides

0.152

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.173

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.428

H2O24 mM hydrogen peroxideDNAdamaging

0.724

Levo10 ug/mL LevofloxacinDNAdamaging

0.983

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.489

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.497

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.769

UVUV-irradiationDNAdamaging

-2.964

ARP41-4 ug/mL Antitubercular compound ARP4?

0.372

Antimycin12.5-50 ug/mL Antimycin A?

-0.201

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.047

PA_110-50 ug/mL Antitubercular compound PA-1?

0.686

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.017

PA8240.2-2 ug/mL PA-824?

0.228

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.477

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.474

Verapamil50 uM Verapamil?

0.221

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.007

methoxatin10-20 ug/mL Methoxatin?